Article
STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells.
Cancer research - 15 Jul 2000
Demoulin J B, Uyttenhove C, Lejeune D, Mui A, Groner B, Renauld J C
Abstract excerpt
Interleukin-9 (IL-9) is a growth factor for T cells and various hematopoietic and lymphoid tumor cells. IL-9 signaling involves activation of Janus kinase (JAK)1 and JAK3 kinases, and signal transducer and activator of transcription (STAT)1, STAT3 and STAT5. Using a dominant negative form of STAT5 (STAT5delta), we demonstrated that this factor is an important mediator of IL-9-dependent Ba/F3 cell growth. Mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
